[ESPR] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
22-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- 6.15%
YoY- 37.67%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 18,980 18,841 18,836 15,401 14,409 40,659 7,978 78.11%
PBT -55,117 -66,324 -56,731 -65,119 -69,386 -43,668 -90,935 -28.35%
Tax 13,494 13,948 13,742 13,430 13,667 11,153 8,139 40.03%
NP -68,611 -80,272 -70,473 -65,119 -69,386 -43,668 -90,935 -17.10%
Tax Rate - - - - - - - -
Total Cost 87,591 99,113 89,309 80,520 83,795 84,327 98,913 -7.77%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -361.49 -426.05 -374.14 -422.82 -481.55 -107.40 -1,139.82 -53.46%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -1.01 -1.27 -1.16 -1.77 -2.62 -1.67 -3.50 -56.29%
EPS Diluted -1.01 -1.27 -1.16 -1.77 -2.62 -1.67 -3.50 -56.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.